Medica Group PLC Dr. Robert Lavis appointed Group Medical Director (8963L)
January 18 2021 - 2:00AM
UK Regulatory
TIDMMGP
RNS Number : 8963L
Medica Group PLC
18 January 2021
18 January 2021
Medica Group Plc
Dr. Robert Lavis appointed Group Medical Director to succeed Dr.
Stephen Davies upon retirement in May 2021
Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the
market leader in the provision of teleradiology services in the UK
and Ireland, announces today that Dr. Stephen Davies has decided to
retire and to step down from his position as Group Medical Director
and as an Executive Director on the Board of Medica. Stephen will
be succeeded as Group Medical Director by the Company's current
Clinical Director, Dr. Robert Lavis. Stephen will work closely with
Robert until his planned departure date of 31 May 2021 to ensure an
orderly transition.
Dr. Davies joined Medica in 2013 and during his tenure he has
transformed the way the service is delivered from a clinical and
governance perspective to establish the Company as the UK leader in
teleradiology. He was also influential in the Company's listing on
the London Stock Exchange in 2017. More recently, Stephen has
played a key role in establishing Medica's presence in Ireland,
following the acquisition of Global Diagnostics Ireland, and in the
deployment of Medica's first augmented intelligence solution.
Dr. Lavis joined the Medica leadership team in September 2020
and has already been influential in driving the clinical aspects of
several key strategic projects, including the delivery of the
Company's first augmented intelligence solution into everyday
reporting practice. He has also driven improvements in clinical
protocols associated with trauma and stroke for urgent NightHawk
reporting. Prior to joining Medica, Robert worked as a reporting
radiologist for the Company for six years. Robert joined Medica
from Gloucester Royal Hospital where he is currently a Consultant
Radiologist and former Clinical Director. He has extensive
experience of clinical practice, starting out his career as a
surgeon before entering radiology with a specialist focus on
oncology.
Dr. Stephen Davies commented:
"It has been a real pleasure for me personally to have been
given the opportunity to lead the clinical governance function at
Medica over the past seven years. There have been many highlights
to speak of but the transformation of Medica into the leading,
clinically-led teleradiology company in the UK and the subsequent
successful listing of the Company on the London Stock Exchange are
amongst the main achievements. I have personally worked alongside
Robert Lavis over the past four months and have no doubt he will
continue the drive to improve and evolve the clinical governance
and quality of the service we deliver at Medica. It has been a
privilege to serve on the Board of Medica and alongside the
Executive team led by Stuart. I wish them all well and look forward
to watching the Company continue to grow from strength to
strength."
Roy Davis, Chairman added:
"On behalf of the Board, I would like to thank Stephen for his
dedication and commitment to Medica over the past seven years, as
well as his participation as a member of the Board. I look forward
to working alongside Robert who shares Stephen's passion for
continuous improvement and his desire to drive change. Robert has
already played a key role in a number of transformative projects
for the Company and I am excited to see him continue to leverage
his experience to deliver meaningful change for the benefit of
Medica's customers, employees and shareholders. I wish Stephen well
in his retirement and know he will be much missed by myself and all
of his colleagues at Medica."
Commenting on his appointment, Dr. Robert Lavis said:
"I am honoured to accept the role of Group Medical Director and
to be stepping into Stephen's shoes. In my role as a radiologist at
Medica and in my short time as Clinical Director, I have seen the
impact that Stephen has made to the clinical processes and
governance at the Company. I am committed to continuing his
excellent work and using my experience and expertise to continue to
improve the quality of our service."
For further information, please contact:
Medica Group Plc:
Roy Davis, Chairman
Stuart Quin, Chief Executive
Officer +44 (0)33 33 111 222
FTI Consulting
Victoria Foster Mitchell
Robert Winder +44 (0)20 3727 1000
About Medica Group PLC
Medica is the market leader in the UK and Ireland for the
provision of teleradiology services, providing outsourced
interpretation and reporting of MRI (magnetic resonance imaging),
CT (computerised tomography), ultrasound and plain film (x-ray)
images, and the market leader for the provision of retinal
diagnostic screening in Ireland. The Company currently offers two
primary services to hospital radiology departments:
-- NightHawk, urgent reporting service, and
-- Elective which includes routine cross-sectional reporting on
MRI and CT scans, and routine plain film reporting on x-ray
images.
Medica contracts with the largest pool of consultant
radiologists in the UK and Ireland, performing remote access
teleradiology across its customer base of more than 100 NHS Trusts
in the UK, the Irish HSE, private hospital groups and diagnostic
imaging companies. This enables the Company to offer a fast,
responsive service both during the day and importantly supporting
urgent out-of-hours reporting.
Medica has developed a bespoke, secure IT platform that provides
market-leading linkage between a hospital's Radiology Information
System (RIS) and consultant radiologists who contract with the
Company. Direct RIS access ensures that where the wider patient
medical history is available, it can be reviewed by the consultant
as part of every report. For more information please visit
www.medica.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOABDGDBCSBDGBU
(END) Dow Jones Newswires
January 18, 2021 02:00 ET (07:00 GMT)
Medica (LSE:MGP)
Historical Stock Chart
From Apr 2024 to May 2024
Medica (LSE:MGP)
Historical Stock Chart
From May 2023 to May 2024